Lake Street Maintains Buy on LifeMD, Lowers Price Target to $3

Benzinga · 1d ago
Lake Street analyst Ryan Meyers maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $5 to $3.